Donald W. Wyatt
Fondatore presso The Wyatt Group LLC
Profilo
Donald W.
Wyatt founded The Wyatt Group LLC in 2009, where he is working as Principal from 2013.
Mr. Wyatt also formerly worked at Isotechnika Pharma, Inc., as Independent Non-Executive Director from 2012 to 2013, Aurinia Pharmaceuticals, Inc., as Independent Director from 2011 to 2013, and CTI BioPharma Corp., as Secretary.
Mr. Wyatt received his graduate degree from Hampshire College.
Posizioni attive di Donald W. Wyatt
| Società | Posizione | Inizio |
|---|---|---|
| The Wyatt Group LLC | Fondatore | 01/01/2009 |
Precedenti posizioni note di Donald W. Wyatt
| Società | Posizione | Fine |
|---|---|---|
Isotechnika Pharma, Inc.
 Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Direttore/Membro del Consiglio | 23/10/2013 |
| AURINIA PHARMACEUTICALS INC. | Direttore/Membro del Consiglio | - |
| CTI BIOPHARMA CORP. | Segretario Aziendale | - |
Formazione di Donald W. Wyatt
| Hampshire College | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| Aziende private | 3 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Health Technology |
| The Wyatt Group LLC | Miscellaneous |
- Borsa valori
- Insiders
- Donald W. Wyatt
